The goal of the developing, interdisciplinary discipline of synthetic biology is to simplify and improve the design, development, and optimization of biological systems. The functionality of biological systems is necessary for advances in synthetic biology. In addition, despite biology's lack of predictability, a rise in the creation of tiny molecules utilising synthetic biology techniques boosts the market. The market for synthetic biology products rises as societal perceptions of synthetic biology change. As a result, major market players are investing in strategic development through activities like acquisition, collaboration, etc. in order to grow their companies and meet demand.
The Global Synthetic Biology Market is estimated to be valued at US$ 13.9 billion in 2022 and is expected to exhibit a CAGR of 28.0% during the forecast period (2022-2030).
Prominent Players in the Synthetic Biology Industry:
1. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. since 1956 offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. It has headquarters based in Waltham, Massachusetts. Thermo Fisher Scientific, the world leader in serving science, in the month of December. 2022 announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Applied Biosystems TaqPath Monkeypox/Orthopox Virus DNA Kit.
2. Synbio Technologies
Founded in 2013 by a group of passionate synthetic biologists with decades of industry experience and a proven track record of delivering cost-effective DNA solutions. Synbio Technologies was incorporated with a single mission in mind: to empower scientific discoveries by providing access to the world’s most advanced synthetic biology tools and services. It has headquarters situated in NJ, USA.
3. Merck KGaA.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
4. Agilent Technologies, Inc.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
5. Amyris
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. In October, 2022 Amyris, Inc. a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, announced a partnership with World Wildlife Fund (WWF), one of the world's leading conservation organizations, to support WWF's efforts to improve ocean health and reduce the impact of fishing on shark populations.
6. Eurofins Genomics GmbH
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
7. Integrated DNA Technologies, Inc.
IDT Corporation provides communications and payment services in the United States and internationally. The company was incorporated in 1978 and is headquartered in Newark, New Jersey. In December, 2022 Integrated DNA Technologies, Inc. (IDT) today announced it closed on the purchase of Next Generation Sequencing (NGS) research assays from Invitae Corporation under the trademarked name Archer®.
8. Codexis, Inc.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. The company was incorporated in 2002 and is headquartered in Redwood City, California. In August, 2022 Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announced the execution of a Commercial License and Enzyme Supply Agreement, enabling Molecular Assemblies to utilize an evolved terminal deoxynucleotidyl transferase (TdT) enzyme in Molecular Assemblies’ Fully Enzymatic Synthesis™ (or FES™) technology.
9. New England Biolabs (UK) Ltd.
The UK subsidiary office of New England Biolabs was founded in 1993 and is located in Hitchin, Hertfordshire. Our UK staff provide dedicated sales and technical support to our customers in the UK. The company has headquarters situated in Hitchin, Herts.
10. Scarab Genomics, LLC
Founded in 2002, Scarab Genomics, an emerging CMO, has created Clean Genome® E. coli, a unique, patented set of bacterial hosts for reliable, high efficiency production of protein and nucleic acid biopharmaceuticals. It has headquarters situated in Madison, WI.
*Definition- Synthetic biology refers to the process of redesigning existing organisms to serve new functions.
